You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti - LAG-3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting
  • NSCLC Stage IV
  • (no location specified)
Mar 15, 2023

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Colorectal Cancer Metastatic Trial (HLX26, HLX10)

Not yet recruiting
  • Colorectal Cancer Metastatic
  • (no location specified)
Oct 14, 2022

Advanced Malignant Tumors(Stage IA-IB) Trial in Beijing (AK129 IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors(Stage IA-IB)
  • AK129 IV infusion
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Jan 17, 2023

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 10, 2022

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 31, 2022

Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Mar 27, 2023

NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Mar 23, 2023

Advanced Solid Tumors Trial in Beijing (BMS-986213)

Recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

Advanced Solid Tumors Trial in Shanghai (Relatlimab, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Relatlimab
  • Nivolumab
  • Shanghai, Shanghai, China
    Local Institution
Aug 10, 2022

Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Dec 20, 2022

Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Aurora, Colorado
  • +17 more
Sep 8, 2022

Adult Solid Tumor Trial (HLX26, HLX10)

Recruiting
  • Adult Solid Tumor
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Oct 17, 2022

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Orlando, Florida
  • +1 more
Jul 5, 2022

Hepatocellular Carcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Solid Tumors, Metastatic Melanoma, NSCLC Trial in Worldwide (RO7247669)

Recruiting
  • Solid Tumors
  • +3 more
  • San Diego, California
  • +20 more
Aug 19, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Grand Rapids, Houston, Toronto (Sym022)

Completed
Has Results
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +2 more
Feb 1, 2021

Cancer Trial in Kashiwa-shi (Relatlimab, Nivolumab)

Active, not recruiting
  • Cancer
  • Kashiwa-shi, Chiba, Japan
    Local Institution
Dec 3, 2021

Tumors by Site Trial in Worldwide (Relatlimab, Nivolumab, BMS-986213)

Active, not recruiting
  • Neoplasms by Site
  • Relatlimab
  • +2 more
  • La Jolla, California
  • +52 more
Feb 10, 2022

Malignancies Trial in Worldwide (REGN3767, cemiplimab)

Active, not recruiting
  • Malignancies
  • Encinitas, California
  • +42 more
Aug 25, 2022

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)

Recruiting
  • Psoriasis
  • Atopic Dermatitis
  • UVB treatment
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 24, 2022

Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck Trial in United States (FS118)

Recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 3, 2022